重药控股: 第八届监事会第三十五次会议决议公告

Group 1 - The company held its 35th meeting of the 8th Supervisory Board on July 10, 2025, with all three supervisors present, and the meeting complied with relevant regulations [1][2] - The Supervisory Board approved the proposal to abolish the Supervisory Board and its members, transferring its powers to the Audit and Risk Committee of the Board of Directors [1][2] - The proposal to amend the company's articles of association was also approved, with details disclosed in a separate announcement [1][2] Group 2 - The company approved a proposal for share repurchase, with the details provided in a separate announcement [2]